AtezoTRIBE: a randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorectal cancer

Antoniotti, C; Borelli, B; Rossini, D; Pietrantonio, F; Morano, F; Salvatore, L; Lonardi, S; Marmorino, F; Tamberi, S; Corallo, S; Tortora, G; Bergamo, F; Brunella, D; Boccaccino, A; Grassi, E; Racca, P; Tamburini, E; Aprile, G; Moretto, R; Boni, L; Falcone, A; Cremolini, C